Oncogenic RAS was shown to induce the secretion of IL-6 in different cell types, such as human kidney cells, fibroblasts, myoblasts and mammary epithelial cell, where this RAS-induced secretion of IL-6 is required for human tumour cell growth in vivo16. Here, IL6 is linked to neoplasm.